{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:45Z","timestamp":1792787865006,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Project of Zhongshan Municipality","award":["No. 2024B1032, 2024B1056"],"award-info":[{"award-number":["No. 2024B1032, 2024B1056"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01857-w","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:18:40Z","timestamp":1760519920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating urinary dual-gene methylation and VI-RADS score to predict residual tumors after TURBT in NMIBC: a nomogram-based model"],"prefix":"10.1186","volume":"25","author":[{"given":"Wang","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qisheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Weiyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Linfeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Yaqiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"3","key":"1857_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1857_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","volume":"78","author":"JY Teoh","year":"2020","unstructured":"Teoh JY, Huang J, Ko WY, et al. Global Trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol. 2020;78(6):893\u2013906.","journal-title":"Eur Urol"},{"issue":"8","key":"1857_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895\u2013904.","journal-title":"World J Urol"},{"issue":"6","key":"1857_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol. 2018;73(6):925\u201333.","journal-title":"Eur Urol"},{"key":"1857_CR5","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, et al. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"issue":"1","key":"1857_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"1","key":"1857_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.ju.0000100480.70769.0e","volume":"171","author":"J Schmidbauer","year":"2004","unstructured":"Schmidbauer J, Witjes F, Schmeller N, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171(1):135\u20138.","journal-title":"J Urol"},{"issue":"2","key":"1857_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.purol.2015.12.001","volume":"26","author":"Y Dabi","year":"2016","unstructured":"Dabi Y, Rouscoff Y, Delongchamps NB, et al. Impact pronostique du genre f\u00e9minin sur le devenir oncologique des patients trait\u00e9s par cystectomie totale [negative prognostic impact of female gender on oncological outcomes following radical cystectomy]. Prog Urol. 2016;26(2):83\u20138.","journal-title":"Prog Urol"},{"issue":"1","key":"1857_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.euf.2023.08.002","volume":"10","author":"W Devlies","year":"2024","unstructured":"Devlies W, de Jong JJ, Hofmann F, et al. The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: a systematic review from the European Association of Urology Guidelines Office. Eur Urol Focus. 2024;10(1):115\u201322.","journal-title":"Eur Urol Focus"},{"issue":"12","key":"1857_CR10","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1007\/s00464-012-2387-0","volume":"26","author":"A Lapini","year":"2012","unstructured":"Lapini A, Minervini A, Masala A, et al. A comparison of hexaminolevulinate (Hexvix(\u00ae)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc. 2012;26(12):3634\u201341.","journal-title":"Surg Endosc"},{"issue":"10","key":"1857_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cncy.21327","volume":"121","author":"H Dimashkieh","year":"2013","unstructured":"Dimashkieh H, Wolff DJ, Smith TM, et al. Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation. Cancer Cytopathol. 2013;121(10):591\u20137.","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"1857_CR12","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3892\/ol.2017.5926","volume":"13","author":"T Lin","year":"2017","unstructured":"Lin T, Liu Z, Liu L, et al. Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma. Oncol Lett. 2017;13(5):3928\u201334.","journal-title":"Oncol Lett"},{"issue":"3","key":"1857_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000456722","volume":"98","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Yoshida S, Tanaka H, et al. Potential utility of diffusion-weighted magnetic resonance imaging in diagnosis of residual bladder cancer before second transurethral resection. Urol Int. 2017;98(3):298\u2013303.","journal-title":"Urol Int"},{"issue":"7","key":"1857_CR14","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1007\/s00261-024-04235-6","volume":"49","author":"SA Khwaja","year":"2024","unstructured":"Khwaja SA, Caglic I, Shaida N, et al. Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT). Abdom Radiol (NY). 2024;49(7):2340\u20138.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"1857_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"key":"1857_CR16","doi-asserted-by":"publisher","first-page":"175628722110395","DOI":"10.1177\/17562872211039583","volume":"13","author":"D S\u00e9guier","year":"2021","unstructured":"S\u00e9guier D, Puech P, Kool R, et al. Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications. Ther Adv Urol. 2021;13:17562872211039584.","journal-title":"Ther Adv Urol"},{"issue":"2","key":"1857_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14737159.2020.1699791","volume":"20","author":"A Lopez-Beltran","year":"2020","unstructured":"Lopez-Beltran A, Cheng L, Gevaert T, et al. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn. 2020;20(2):231\u201343.","journal-title":"Expert Rev Mol Diagn"},{"issue":"10","key":"1857_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas M, Todenh\u00f6fer T, Black PC. Urine biomarkers in bladder cancer - current status and future perspectives. Nat Rev Urol. 2023;20(10):597\u2013614.","journal-title":"Nat Rev Urol"},{"issue":"17","key":"1857_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","volume":"24","author":"A Papanicolau-Sengos","year":"2022","unstructured":"Papanicolau-Sengos A, Aldape K. DNA methylation profiling: an emerging paradigm for cancer diagnosis. Annu Rev Pathol. 2022;24(17):295\u2013321.","journal-title":"Annu Rev Pathol"},{"issue":"7","key":"1857_CR20","doi-asserted-by":"publisher","first-page":"15029","DOI":"10.3390\/ijms140715029","volume":"14","author":"Y Delpu","year":"2013","unstructured":"Delpu Y, Cordelier P, Cho WC, et al. DNA methylation and cancer diagnosis. Int J Mol Sci. 2013;14(7):15029\u201358.","journal-title":"Int J Mol Sci"},{"key":"1857_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1200\/JCO.2024.42.4_suppl.623","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Cai L, Zhen B, et al. Performance of the OncoUrine test on predicting patients who can avoid Re-TURBT and prognosis: a prospective, multicenter clinical study. JCO. 2024;42:623\u2013623.","journal-title":"JCO"},{"key":"1857_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cancergen.2021.12.001","volume":"260\u2013261","author":"M El Azzouzi","year":"2022","unstructured":"El Azzouzi M, El Ahanidi H, Hafidi Alaoui C, et al. Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients. Cancer Genet. 2022;260\u2013261:41\u20135.","journal-title":"Cancer Genet"},{"issue":"1","key":"1857_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejca.2013.08.025","volume":"50","author":"S Monteiro-Reis","year":"2014","unstructured":"Monteiro-Reis S, Le\u00e7a L, Almeida M, et al. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation. Eur J Cancer. 2014;50(1):226\u201333.","journal-title":"Eur J Cancer"},{"issue":"23","key":"1857_CR24","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1158\/1078-0432.CCR-10-1312","volume":"16","author":"VL Costa","year":"2010","unstructured":"Costa VL, Henrique R, Danielsen SA, et al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin Cancer Res. 2010;16(23):5842\u201351.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1857_CR25","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","volume":"36","author":"F Soria","year":"2018","unstructured":"Soria F, Droller MJ, Lotan Y, et al. An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J Urol. 2018;36(12):1981\u201395.","journal-title":"World J Urol"},{"issue":"4","key":"1857_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/ijms20040821","volume":"20","author":"E Oeyen","year":"2019","unstructured":"Oeyen E, Hoekx L, De Wachter S, et al. Bladder cancer diagnosis and follow-up: the current status and possible role of extracellular vesicles. Int J Mol Sci. 2019;20(4):821.","journal-title":"Int J Mol Sci"},{"key":"1857_CR27","doi-asserted-by":"publisher","first-page":"147352","DOI":"10.1016\/j.gene.2023.147352","volume":"866","author":"N Varol","year":"2023","unstructured":"Varol N, Keles \u0130, Yildiz H, et al. Methylation analysis of histone 4-related gene HIST1H4F and its effect on gene expression in bladder cancer. Gene. 2023;866:147352.","journal-title":"Gene"},{"issue":"48","key":"1857_CR28","doi-asserted-by":"publisher","first-page":"79956","DOI":"10.18632\/oncotarget.13182","volume":"7","author":"C Cao","year":"2016","unstructured":"Cao C, Sun D, Zhang L, et al. miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1. Oncotarget. 2016;7(48):79956\u201363.","journal-title":"Oncotarget"},{"issue":"7","key":"1857_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/dna.2013.2030","volume":"32","author":"Z Yegin","year":"2013","unstructured":"Yegin Z, Gunes S, Buyukalpelli R. Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients. DNA Cell Biol. 2013;32(7):386\u201392.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"1857_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2009.07.041","volume":"58","author":"I Renard","year":"2009","unstructured":"Renard I, Joniau S, et al. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. Eur Urol. 2009;58(1):96\u2013104.","journal-title":"Eur Urol"},{"issue":"1","key":"1857_CR31","doi-asserted-by":"publisher","first-page":"e1549","DOI":"10.1002\/ctm2.1549","volume":"14","author":"W Ouyang","year":"2024","unstructured":"Ouyang W, Xu R, Yao H, et al. Urinary DNA methylation-based risk stratification model to triage patients for repeat transurethral resection of bladder tumours. Clin Transl Med. 2024;14(1):e1549.","journal-title":"Clin Transl Med"},{"issue":"2","key":"1857_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, Sahin AF, Yildirim U, et al. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol. 2010;58(2):185\u201390.","journal-title":"Eur Urol"},{"issue":"6","key":"1857_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.acuro.2020.08.016","volume":"45","author":"F Pisano","year":"2021","unstructured":"Pisano F, Gontero P, Sylvester R, et al. Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. Actas Urol Esp (Engl Ed). 2021;45(6):473\u20138.","journal-title":"Actas Urol Esp (Engl Ed)"},{"issue":"4","key":"1857_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MOU.0000000000000892","volume":"31","author":"VM Schuettfort","year":"2021","unstructured":"Schuettfort VM, Pradere B, Comp\u00e9rat E, et al. Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review. Curr Opin Urol. 2021;31(4):324\u201331.","journal-title":"Curr Opin Urol"},{"issue":"2","key":"1857_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/bju.15622","volume":"129","author":"MS Wettstein","year":"2022","unstructured":"Wettstein MS, Baxter NN, Sutradhar R, et al. Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness study. BJU Int. 2022;129(2):258\u201368.","journal-title":"BJU Int"},{"key":"1857_CR36","doi-asserted-by":"crossref","unstructured":"Razin A, Shemer R. DNA methylation in early development. Hum Mol Genet. 1995;4:1751\u20135.","DOI":"10.1093\/hmg\/4.suppl_1.1751"},{"issue":"4","key":"1857_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3233\/CBM-160261","volume":"18","author":"JJ Fantony","year":"2017","unstructured":"Fantony JJ, Longo TA, Gopalakrishna A, et al. Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer. Cancer Biomark. 2017;18(4):381\u20137.","journal-title":"Cancer Biomark"},{"issue":"1","key":"1857_CR38","doi-asserted-by":"publisher","first-page":"51.e21","DOI":"10.1016\/j.urolonc.2013.08.003","volume":"32","author":"MR Abern","year":"2014","unstructured":"Abern MR, Owusu R, Inman BA. Clinical performance and utility of a DNA methylation urine test for bladder cancer. Urol Oncol. 2014;32(1):51.e21-51.e5.1E26.","journal-title":"Urol Oncol."},{"issue":"24","key":"1857_CR39","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1158\/0008-5472.CAN-19-1019","volume":"79","author":"S Dong","year":"2019","unstructured":"Dong S, Li W, Wang L, et al. Histone-related genes are hypermethylated in lung cancer and hypermethylated HIST1H4F could serve as a pan-cancer biomarker. Cancer Res. 2019;79(24):6101\u201312.","journal-title":"Cancer Res"},{"issue":"10","key":"1857_CR40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41388-023-02936-8","volume":"43","author":"H Cai","year":"2024","unstructured":"Cai H, Ke ZB, Chen JY, et al. Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing TWIST1. Oncogene. 2024;43(10):703\u201313.","journal-title":"Oncogene"},{"issue":"1","key":"1857_CR41","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1038\/s41598-024-58586-7","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Xu X, Wang T, et al. Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1\/Vimentin to detect urothelial carcinoma of the bladder. Sci Rep. 2024;14(1):7941.","journal-title":"Sci Rep"},{"issue":"10","key":"1857_CR42","doi-asserted-by":"publisher","first-page":"e46297","DOI":"10.1371\/journal.pone.0046297","volume":"7","author":"T Reinert","year":"2012","unstructured":"Reinert T, Borre M, Christiansen A, et al. Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation. PLoS One. 2012;7(10):e46297.","journal-title":"PLoS One"},{"issue":"1","key":"1857_CR43","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1038\/s41598-025-91337-w","volume":"15","author":"WD Wang","year":"2025","unstructured":"Wang WD, Yang XR, Li WH, et al. Analysis the diagnostic performance of H4C6\/SOX1-OT gene methylation in bladder cancer based on urine sample. Sci Rep. 2025;15(1):6961.","journal-title":"Sci Rep"},{"issue":"3","key":"1857_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.urolonc.2013.06.001","volume":"32","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Kluth LA, Rieken M, et al. Urine markers for detection and surveillance of bladder cancer. Urol Oncol. 2014;32(3):222\u20139.","journal-title":"Urol Oncol"},{"issue":"12","key":"1857_CR45","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang J, Ruan W, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest. 2020;130(12):6278\u201389.","journal-title":"J Clin Invest"},{"issue":"3","key":"1857_CR46","doi-asserted-by":"publisher","first-page":"26142","DOI":"10.31083\/FBL26142","volume":"30","author":"OM Damiano","year":"2025","unstructured":"Damiano OM, Stevens AJ, Kenwright DN, et al. Chronic inflammation to cancer: the impact of oxidative stress on DNA methylation. Front Biosci (Landmark Ed). 2025;30(3):26142.","journal-title":"Front Biosci (Landmark Ed)"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01857-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:03:43Z","timestamp":1760522623000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01857-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01857-w","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research and Experimental Animal Ethics Committee of Zhongshan City People\u2019s Hospital (Ethics Approval Number: 2024\u2013128). The study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Informed consent was obtained from all patients and their families prior to participation.Informed consent was obtained from all individual patients and their families included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that informed consent for publication was obtained from all patients and their families.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}